Standard & Poor’s has affirmed its ‘A-‘ counterparty credit and financial strength ratings and negative outlook on Amedex Insurance Co.
Standard & Poor’s subsequently withdrew the ratings at the company’s request. The ratings reflected Amedex’s good business position as a niche provider of major medical products in Latin America, favorable operating performance, and strong capitalization.
These positive factors are offset by Amedex’s limited size, declining enrollment trends, new business risk through Amedex Bermuda, and high operating expenses, which are the direct consequence of its target market and high level of service provided.
Was this article valuable?
Here are more articles you may enjoy.
Wells Fargo Sued by Ex-Manager Who Said Bank Faked Diversity
Apollo Expands Asset-Level Risk Reviews to Reflect Impact of Extreme Weather
LA Fires Push Insurers’ 2025 Disaster Losses to $107 Billion
Waymo to Update Software Across Fleet After Major Power Failure